A citation-based method for searching scientific literature

Giulia Ferrannini, Gianluigi Savarese, Lars Rydén. Diabetes Res Clin Pract 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice.
Christoffer Clemmensen, Brian Finan, Katrin Fischer, Robby Zachariah Tom, Beata Legutko, Laura Sehrer, Daniela Heine, Niklas Grassl, Carola W Meyer, Bart Henderson,[...]. EMBO Mol Med 2015
47
50

Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
Sheng-Hua Yang, Rui-Xia Xu, Chuan-Jue Cui, Yin Wang, Ying Du, Zhi-Guo Chen, Yu-Hong Yao, Chun-Yan Ma, Cheng-Gang Zhu, Yuan-Lin Guo,[...]. Cardiovasc Diabetol 2018
22
50

Impact of the Glucagon Assay When Assessing the Effect of Chronic Liraglutide Therapy on Glucagon Secretion.
Caroline K Kramer, Bernard Zinman, Haysook Choi, Philip W Connelly, Ravi Retnakaran. J Clin Endocrinol Metab 2017
10
50

Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease.
Sneha Kothari, Hiteshi Dhami-Shah, Samir R Shah. J Clin Exp Hepatol 2019
17
50



Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis.
Nikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, Sanne S Veidal, Christos S Mantzoros. Liver Int 2021
3
50


Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes.
Maria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, Biagio Arcidiacono, Domenica Maria Corigliano, Stefania Giuliano, Francesco Saverio Brunetti, Sinan Tanyolaç, Daniela Patrizia Foti, Luigi Puccio,[...]. Int J Environ Res Public Health 2019
13
50

SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans.
Heeyoung Chae, Robert Augustin, Eva Gatineau, Eric Mayoux, Mohammed Bensellam, Nancy Antoine, Firas Khattab, Bao-Khanh Lai, Davide Brusa, Birgit Stierstorfer,[...]. Mol Metab 2020
9
50

Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
Paul Millar, Nupur Pathak, Vadivel Parthsarathy, Anthony J Bjourson, Maurice O'Kane, Varun Pathak, R Charlotte Moffett, Peter R Flatt, Victor A Gault. J Endocrinol 2017
35
50

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono,[...]. Int J Mol Sci 2020
21
50

Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24-week, prospective, randomized, placebo-controlled pilot trial.
Jürgen Harreiter, Ivica Just, Michael Leutner, Magdalena Bastian, Helmut Brath, Christian Schelkshorn, Radka Klepochova, Martin Krššák, Alexandra Kautzky-Willer. Diabetes Obes Metab 2021
7
50


Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice.
Mette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejà, Pernille Wismann, Katrine Fabricius, Kristoffer Rigbolt, Martin Mikkelsen, Morten Sommer, Jacob Jelsing, Henrik Bjørn Nielsen,[...]. Sci Rep 2019
19
50


The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.
Yasushi Honda, Kento Imajo, Takayuki Kato, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Shingo Kato, Hironori Mawatari, Koji Fujita, Masato Yoneda,[...]. PLoS One 2016
103
50

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.
Amalia Gastaldelli, Enrico Repetto, Cristian Guja, Elise Hardy, Jenny Han, Serge A Jabbour, Ele Ferrannini. Diabetes Obes Metab 2020
25
50

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
50

Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice.
Xianlong Ye, Jianying Qi, Guiping Ren, Pengfei Xu, Yunzhou Wu, Shenglong Zhu, Dan Yu, Shujie Li, Qiang Wu, Rasool Lubna Muhi,[...]. Endocrine 2015
13
50

Mechanisms of regulation of gene expression by fatty acids.
Manabu T Nakamura, Yewon Cheon, Yue Li, Takayuki Y Nara. Lipids 2004
124
50


Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J Clin Invest 2014
634
50

Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis.
Chrysanthi Mantsiou, Thomas Karagiannis, Panagiota Kakotrichi, Konstantinos Malandris, Ioannis Avgerinos, Aris Liakos, Apostolos Tsapas, Eleni Bekiari. Diabetes Obes Metab 2020
10
50


Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation.
Brent A McLean, Chi Kin Wong, Jonathan E Campbell, David J Hodson, Stefan Trapp, Daniel J Drucker. Endocr Rev 2021
20
50

Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators.
Juan Decara, Sergio Arrabal, Daniel Beiroa, Patricia Rivera, Antonio Vargas, Antonia Serrano, Francisco Javier Pavón, Joan Ballesteros, Carlos Dieguez, Rubén Nogueiras,[...]. Biofactors 2016
19
50

Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.
Jamie E Mells, Ping P Fu, Shvetank Sharma, Darin Olson, Lihong Cheng, Jeffrey A Handy, Neeraj K Saxena, Dan Sorescu, Frank A Anania. Am J Physiol Gastrointest Liver Physiol 2012
150
50


Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes.
Tomohiko Kimura, Hideaki Kaneto, Masashi Shimoda, Hidenori Hirukawa, Seizo Okauchi, Kenji Kohara, Sumiko Hamamoto, Kazuhito Tawaramoto, Mitsuru Hashiramoto, Kohei Kaku. Mol Cell Endocrinol 2015
36
50

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
Aurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad A Abdul-Ghani,[...]. J Clin Invest 2014
477
50

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
50

A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.
Caroline W Cohen, Kevin R Fontaine, Rebecca C Arend, Ronald D Alvarez, Charles A Leath, Warner K Huh, Kerri S Bevis, Kenneth H Kim, John M Straughn, Barbara A Gower. J Nutr 2018
48
50

To Keto or Not to Keto? A Systematic Review of Randomized Controlled Trials Assessing the Effects of Ketogenic Therapy on Alzheimer Disease.
Maria G Grammatikopoulou, Dimitrios G Goulis, Konstantinos Gkiouras, Xenophon Theodoridis, Kalliopi K Gkouskou, Athanasios Evangeliou, Efthimis Dardiotis, Dimitrios P Bogdanos. Adv Nutr 2020
10
50

Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.
Guilherme Moura Cunha, German Guzman, Livia Lugarinho Correa De Mello, Barbara Trein, Luciana Spina, Isabela Bussade, Juliana Marques Prata, Ignacio Sajoux, Walmir Countinho. Front Endocrinol (Lausanne) 2020
9
50

Effects of ketogenic diet and ketone bodies on the cardiovascular system: Concentration matters.
Souad Nasser, Varvara Vialichka, Marta Biesiekierska, Aneta Balcerczyk, Luciano Pirola. World J Diabetes 2020
6
50

Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus.
A Goday, D Bellido, I Sajoux, A B Crujeiras, B Burguera, P P García-Luna, A Oleaga, B Moreno, F F Casanueva. Nutr Diabetes 2016
79
50

Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction.
Kevin J Pearson, Kaitlyn N Lewis, Nathan L Price, Joy W Chang, Evelyn Perez, Maria Victoria Cascajo, Kellie L Tamashiro, Suresh Poosala, Anna Csiszar, Zoltan Ungvari,[...]. Proc Natl Acad Sci U S A 2008
151
50

Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum.
Alexandra M Johnstone, Graham W Horgan, Sandra D Murison, David M Bremner, Gerald E Lobley. Am J Clin Nutr 2008
191
50

Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Tim Heise, Roberto Bizzotto, Andrea Mari, Thomas R Pieber, Elza Muscelli. Diabetes 2016
283
50



Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity.
Ignacio Sajoux, Paula M Lorenzo, Diego Gomez-Arbelaez, M Angeles Zulet, Itziar Abete, Ana I Castro, Javier Baltar, María P Portillo, Francisco J Tinahones, J Alfredo Martinez,[...]. Nutrients 2019
21
50

Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats.
M Snorek, D Hodyc, V Sedivý, J Durišová, A Skoumalová, J Wilhelm, J Neckář, F Kolář, J Herget. Physiol Res 2012
31
50

Regulation of low-density lipoprotein subfractions by carbohydrates.
Philipp A Gerber, Kaspar Berneis. Curr Opin Clin Nutr Metab Care 2012
15
50

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
Nicole Jacqueline Jensen, Helena Zander Wodschow, Malin Nilsson, Jørgen Rungby. Int J Mol Sci 2020
22
50

The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.
Simon A Hawley, Rebecca J Ford, Brennan K Smith, Graeme J Gowans, Sarah J Mancini, Ryan D Pitt, Emily A Day, Ian P Salt, Gregory R Steinberg, D Grahame Hardie. Diabetes 2016
160
50

Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses.
Eric C Westman, William S Yancy, Maren K Olsen, Tara Dudley, John R Guyton. Int J Cardiol 2006
68
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.